Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
market exclusivity expired at the end of May 2017. Numerous companies applied for marketing authorisations in Germany, including Glenmark. Success in PI Although Mundipharma’s key patent EP 1 492 505
another patent infringement complaint in the Eastern District of Texas. Following a two-year investigation last November, the Administrative Law Judge (ALJ) found that while BOE had infringed three of
Context: In general, Unified Patent Court (UPC) practitioners are well aware of the implications of the young judiciary’s frontloaded proceedings. Anything that can be pleaded early must be pleaded
In the ongoing dispute over its highly successful weight-loss drug semaglutide, Novo Nordisk has suffered a further setback as the EPO revoked yet another patent from several under attack. After the
MU Ionics and CATL have resolved their patent disputes. They recently signed a licence deal that also impacts Opel, which uses the Chinese battery manufacturer's products in its electric vehicles and
light of day. Plaintiff MED-EL and its opponent Advanced Bionics have reached a settlement to end all ongoing disputes over cochlear implants. MED-EL has confirmed this to JUVE Patent. The opponents were
Germany (March 3, 2025 ip fray article). Infringement litigation is also progressing. For example, ZTE obtained a standard-essential patent (SEP) preliminary injunction in Brazil (February 13, 2025 ip
, projected to be worth $11.4 billion by 2031 (January 2025 IndustryArc report). In parallel, the Qi-related patent market has seen significant momentum, with a number of lawsuits emerging, including in the
Slip-on trainers are known in Europe primarily through Nike, which licenses the technology from patent holder Kizik. Now global footwear brand Skechers has entered the market and faces infringement
patent holder Regeneron, the drug achieved global sales of around $9 billion in 2023. Bayer and Regeneron are fighting hard to retain market exclusivity. The dispute spans numerous European countries
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
